A study to compare the effects of two drug regimes Terlipressin plus Albumin Vs Midodrine,Octreotide plus Albumin in the treatment of a fatal complication of Chronic Liver Disease which effects the Kidney function (Hepatorenal Syndrome)
Phase 4
- Conditions
- Health Condition 1: K767- Hepatorenal syndrome
- Registration Number
- CTRI/2024/03/064877
- Lead Sponsor
- Ananya Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patient 18 years or older of both sexes
2)Patients diagnosed with HRS
Exclusion Criteria
1)Contraindications to Terlipressin
2)Patients diagnosed with chronic kidney disease
3)Child Pugh Score more than 13
4)Ongoing shock or uncontrolled bacterial infection
5)Current or recent treatment with nephrotoxic drugs
6)Presence of cardiovascular diseases and any extra hepatic diseases that could affect the short term prognosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method